age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
80.62396
|
female
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 9
|
$11-$25k
| 100
| 5,328
| 3,825.4981
| 3,869.93945
| 29
|
white
| 39.09375
| 60
| 0.004
| 0
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 56
| 16.199219
| 96
| 13
| 36.09375
| null | 2.399902
| 0.799927
| 6.5
| 139
| null | 162
| 60
| 304
| null | null |
<2 mo. follow-up
| 4.129883
| 3
| 1
|
64.159
|
male
| 0
| 84
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 37
| 196,926
| 140,458.25
| 134,407.625
| 23.25
|
white
| 27.5
| 83
| 0.513916
| 0.397949
| 17
| 1
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 84
| 63
| 21.597656
| 104
| 10
| 37.89844
| 292
| 2.5
| 0.199982
| 4.5
| 133
| 7.399414
| 236
| 34
| 195
| null | null |
Coma or Intub
| 2.669922
| 1,030
| 0
|
71.20599
|
male
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 19
|
>$50k
| 41
| 81,716
| 57,042.6875
| 54,791.5938
| 45.666657
|
white
| 37.195313
| 69
| 0.127991
| 0.057999
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.25
|
dnr after sadm
| 18
| 101
| 7.799805
| 107
| 22
| 35.5
| null | 3.699707
| 0.699951
| 1.299805
| 135
| null | 123
| 16
| 3,400
| null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
76.01398
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
$25-$50k
| 0
| 8,210
| 5,734.2891
| 4,731.03906
| 10
|
white
| 20.097656
| 31
| 0.825928
| 0.715942
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 11
| 63
| 0.799927
| 124
| 32
| 40.29688
| null | null | null | 1
| 140
| null | 152
| 23
| 2,725
| null | 0
|
no(M2 and SIP pres)
| 0
| 89
| 1
|
76.86499
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| null |
under $11k
| 37
| 34,265
| 22,998.5156
| 25,846.0469
| 35.5
|
white
| 28.398438
| 46
| 0.345947
| 0.22998
| 7
| 0
| 0
|
yes
| 0.75
| 0.75
|
dnr before sadm
| -6
| 70
| 5.299805
| 71
| 20
| 36.79688
| 257.125
| 4.199219
| 0.299988
| 0.899902
| 140
| 7.519531
| 105
| 7
| 3,400
| null | 5
|
<2 mo. follow-up
| 5
| 10
| 1
|
76.05695
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 7,822
| 5,231.5078
| 5,692.80859
| 8.5
|
white
| 20.097656
| 18
| 0.781982
| 0.710938
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 7
| 77
| 9.798828
| 64
| 24
| 35.29688
| null | 4.299805
| 0.799927
| 1.199951
| 137
| null | 123
| 23
| null | null | 6
| null | 6
| 468
| 1
|
58.65598
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 10
| null | 0
| 6,493
| 4,331.8125
| 4,826.31641
| 7
|
white
| 13.5
| 23
| 0.932983
| 0.886963
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 10
| 108
| 32.695313
| 122
| 28
| 36.19531
| 209.5
| 3
| 0.599976
| 0.799927
| 140
| 7.40918
| 210
| 25
| 2,000
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,025
| 0
|
42.66098
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 10
|
>$50k
| 0
| 4,419
| 2,632.5547
| 1,728.67969
| 12
|
white
| 16.898438
| 14
| 0.85498
| 0.677979
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 63
| 4.099609
| 101
| 22
| 36.09375
| 296.25
| null | null | 0.799927
| 148
| 7.419922
| 139
| 11
| 570
| null | null |
<2 mo. follow-up
| 1.775147
| 7
| 1
|
49.37698
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
$25-$50k
| 41
| 24,837
| 17,625.0469
| 19,236.6719
| 23.5
|
white
| 29.796875
| 32
| 0.570923
| 0.459961
| 5
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 13
| 105
| 10.699219
| 81
| 24
| 36.19531
| null | null | null | 1.599854
| 136
| null | 218
| 19
| 2,375
| null | 1
|
no(M2 and SIP pres)
| 1
| 1,022
| 0
|
58.81198
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 20
| null | 0
| 11,502
| 7,187.3828
| 7,626.59766
| 8
|
white
| 16
| 24
| 0.909912
| 0.848999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 83
| 14.298828
| 70
| 28
| 36.59375
| 122.4375
| null | null | 1.199951
| 134
| 7.279297
| 220
| 21
| 2,750
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,024
| 0
|
44.79099
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 6,825
| 3,957.3223
| 1,819.3291
| 10
|
white
| 14.298828
| 8
| 0.796997
| 0.56897
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.9
|
no dnr
| 5
| 67
| 16.097656
| 56
| 24
| 36.39844
| 207.5
| null | null | 2.099609
| 140
| 7.329102
| 110
| 61
| 1,600
| null | null |
no(M2 and SIP pres)
| 1.929199
| 423
| 1
|
57.80197
|
female
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 8,502
| 5,531.3594
| 6,651.1875
| 20.5
|
white
| 21.296875
| 36
| 0.783936
| 0.653931
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 11
| 105
| 33
| 140
| 30
| 36.79688
| 220
| 3.299805
| 0.599976
| 1.099854
| 152
| 7.519531
| 169
| 38
| 1,300
| null | null | null | 2.643066
| 932
| 1
|
95.34796
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
$25-$50k
| 0
| 2,889
| 2,034.4414
| 1,931.69922
| 5
|
white
| 18.5
| 23
| 0.772949
| 0.637939
| 1
| 1
| 0
|
no
| 0.99
| 0.98
|
no dnr
| 4
| 96
| 6.699219
| 62
| 16
| 37.19531
| null | 3.599609
| 0.199982
| 1.399902
| 139
| null | 92
| 19
| 875
| null | null |
no(M2 and SIP pres)
| 3.210449
| 574
| 1
|
78.40399
|
female
| 0
| 11
|
Coma
|
Coma
| 1
| 12
|
under $11k
| 44
| 18,964
| 12,842.6953
| 13,325.2969
| 10.5
|
white
| 16.796875
| 23
| 0.562988
| 0.494995
| 1
| 0
| 0
|
no
| 0.3
| 0.1
|
dnr after sadm
| 4
| 110
| 9.798828
| 215
| 24
| 35.89844
| 261.875
| 3.399902
| 0.399963
| 0.699951
| 138
| 7.40918
| 219
| 11
| 1,050
| null | 0
|
<2 mo. follow-up
| 0
| 34
| 1
|
66.85596
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 30,742
| 21,348.7344
| 19,812.7969
| 14
|
hispanic
| 21.597656
| 30
| 0.74292
| 0.662964
| 7
| 0
| 0
|
yes
| 0.8
| 0.75
|
no dnr
| 17
| 109
| 1.099854
| 81
| 24
| 36.19531
| 292.5625
| 4
| 0.799927
| 1.099854
| 141
| 7.379883
| 209
| 24
| 700
| null | null |
no(M2 and SIP pres)
| 2.117676
| 1,019
| 0
|
68.862
|
male
| 0
| 39
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 37
| 64,543
| 42,614.5
| 44,507.9688
| 35.5
|
white
| 39.59375
| 81
| 0.058998
| 0.019997
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.3
|
dnr after sadm
| 27
| 59
| 23.398438
| 120
| 28
| 35.59375
| 67.76562
| 2
| 1.099854
| 1.199951
| 148
| 7.25
| 237
| 37
| 2,900
| null | 1
|
no(M2 and SIP pres)
| 1
| 200
| 1
|
76.24097
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 5,039
| 3,335.2715
| 3,161.12891
| 3.5
|
white
| 14.199219
| 33
| 0.842896
| 0.74292
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 7
| 54
| 14.5
| 72
| 16
| 38.19531
| 237.5
| 2
| 1.599854
| 3.399902
| 132
| 7.329102
| 151
| 86
| 1,150
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,017
| 0
|
53.55197
|
female
| 0
| 8
|
Coma
|
Coma
| 1
| 12
|
$11-$25k
| 44
| 21,253
| 16,260.5625
| 18,439.3281
| 17.5
|
white
| 17.398438
| 11
| 0.68396
| 0.62793
| 1
| 0
| 0
|
yes
| 0.5
| 0.1
|
no dnr
| 8
| 38
| 10.398438
| 49
| 24
| 35.79688
| 156.25
| 3.099609
| 8.298828
| 3
| 135
| 7.269531
| 74
| 95
| 30
| null | 2
|
<2 mo. follow-up
| 2
| 36
| 1
|
58.62299
|
female
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 13
|
$11-$25k
| 0
| 14,096
| 9,527.4844
| 10,530.1484
| 10.666664
|
white
| 23.5
| 35
| 0.855957
| 0.762939
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 15
| 72
| 16.296875
| 124
| 16
| 38.29688
| 316
| 2.199707
| 6.699219
| 0.899902
| 130
| 7.479492
| 171
| 2
| 4,660
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 164
| 1
|
91.96698
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 4
|
under $11k
| 0
| 6,512
| 4,440.8672
| 3,682.92969
| 5
|
white
| 24.5
| 32
| 0.67688
| 0.505981
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 61
| 52.398438
| 101
| 28
| 36.39844
| 266.625
| 4
| 0.799927
| 1.599854
| 129
| 7.449219
| 124
| 26
| 3,380
| null | 2
|
<2 mo. follow-up
| 2
| 31
| 1
|
70.20398
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 1,742
| 1,199.4209
| 1,106.15918
| 5
|
white
| 14.298828
| 27
| 0.899902
| 0.831909
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 2
| 125
| null | 114
| 20
| 36.5
| 242.84375
| 3.599609
| 0.5
| 1.5
| 129
| 7.40918
| 135
| 15
| 2,725
| null | null |
<2 mo. follow-up
| 1.901123
| 9
| 1
|
73.47595
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 4,644
| 3,087.9258
| 2,881.76953
| 7
|
white
| 3.299805
| 12
| 0.929932
| 0.834961
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 8
| 115
| 8.099609
| 81
| 24
| 36.29688
| 208.6875
| 3.799805
| 0.199982
| 0.599976
| 135
| 7.329102
| 190
| 6
| 4,050
| null | null | null | 1.911133
| 277
| 1
|
67.146
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 11
| null | 0
| 6,888
| 4,779.3477
| 3,852.16992
| 11
|
white
| 24.398438
| 47
| 0.800903
| 0.677979
| 1
| 1
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 9
| 41
| 7.199219
| 97
| 20
| 37.79688
| null | null | null | 10.199219
| 130
| null | 135
| 54
| 0
| 2
| 3
|
no(M2 and SIP pres)
| 3
| 1,011
| 0
|
35.978
|
female
| 1
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 123,597
| 76,373.9375
| 122,543.812
| 40.25
|
white
| 31.5
| 44
| 0.751953
| 0.67395
| 1
| 0
| 0
|
yes
| 0.85
| 0.25
|
dnr after sadm
| 28
| 114
| 14.298828
| 107
| 24
| 37.79688
| null | 2.699707
| 0.299988
| 6.599609
| 125
| null | 169
| 31
| 0
| null | 0
|
<2 mo. follow-up
| 0
| 32
| 1
|
78.65796
|
male
| 0
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 51,280
| 33,954.9688
| 36,876.6875
| 20.333328
|
white
| 30.199219
| 40
| 0.480957
| 0.362976
| 3
| 1
| 0
|
yes
| null | null |
no dnr
| 21
| 63
| 19.199219
| 59
| 7
| 38.69531
| 150
| 2
| 0.5
| 2.299805
| 141
| 7.40918
| 113
| 33
| 1,670
| null | null | null | 2.404785
| 264
| 1
|
73.97894
|
female
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 8
| null | 26
| 13,754
| 9,171.4688
| 7,574.55859
| 7.333332
|
white
| 14.798828
| 10
| 0.840942
| 0.738892
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 1
| 63
| 5.399414
| 58
| 10
| 39.29688
| 152
| 2.899902
| 11.298828
| 0.799927
| 135
| 7.459961
| 168
| 10
| 750
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 562
| 1
|
21.60199
|
female
| 0
| 64
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$11-$25k
| 26
| 184,711
| 117,790.562
| 122,645.188
| 46.5
|
white
| 26.097656
| 40
| 0.802979
| 0.736938
| 15
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 64
| 115
| 14.199219
| 70
| 14
| 36.29688
| 242.84375
| 3.699707
| 0.5
| 3.599609
| 139
| 7.279297
| 247
| 80
| 1,900
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,010
| 0
|
83.02795
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 44
| 76,505
| 49,727.5938
| 51,341.3125
| 24.25
|
white
| 39
| 66
| 0.072998
| 0.025997
| 13
| 1
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 24
| 102
| 7.299805
| 60
| 24
| 35.69531
| 285.6875
| 3.399902
| 0.799927
| 1.599854
| 134
| 7.579102
| 88
| 39
| null | null | 5
|
<2 mo. follow-up
| 5
| 36
| 1
|
62.35199
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 8
| null | 26
| 9,029
| 7,019.7617
| 7,303.75
| 7.5
|
white
| 16.398438
| 25
| 0.628906
| 0.316956
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
no dnr
| 12
| 70
| 14.798828
| 68
| 14
| 39
| 162.5
| 3.299805
| 0.299988
| 1.199951
| 140
| 7.549805
| 126
| 26
| 2,250
| null | 0
|
no(M2 and SIP pres)
| 0
| 94
| 1
|
88.20496
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 5,190
| 3,528.1582
| 3,333.84961
| 7.5
|
white
| 22.699219
| 32
| 0.733887
| 0.583984
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
dnr after sadm
| 1
| 54
| 21.097656
| 54
| 36
| 38.79688
| 122.84375
| 3.399902
| 0.5
| 1.599854
| 137
| 7.379883
| 145
| 45
| 1,975
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,007
| 0
|
43.80298
|
male
| 1
| 162
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 357,329
| 247,808.5
| 261,157.875
| 43.25
|
hispanic
| 39.898438
| 64
| 0.5979
| 0.48999
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 144
| 113
| 52.898438
| 68
| 28
| 38.29688
| 140
| 3
| 0.399963
| 1
| 136
| 7.359375
| 192
| 49
| 410
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 162
| 1
|
79.73999
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 32,877
| 21,715.0469
| 18,913.125
| 11.75
|
white
| 35.59375
| 58
| 0.452942
| 0.333984
| 2
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 29
| 50
| 10.5
| 138
| 10
| 38.19531
| 124.28125
| 2.199707
| 0.5
| 1.099854
| 142
| 7.399414
| 126
| 28
| 1,925
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,005
| 0
|
43.50198
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 26
| 115,064
| 74,479.25
| 72,744.3125
| 20.5
|
hispanic
| 28.296875
| 38
| 0.575928
| 0.464966
| 69
| 0
| 0
|
yes
| 0.5
| 0.125
|
no dnr
| 28
| 113
| 7.699219
| 110
| 10
| 38.19531
| 268.5625
| 4
| 0.799927
| 0.599976
| 140
| 7.399414
| 147
| 9
| 2,000
| null | 0
| null | 0
| 1,002
| 0
|
77.47296
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 0
| 4,194
| 2,887.7383
| 2,590.0293
| 11
|
white
| 18
| 25
| 0.846924
| 0.747925
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 6
| 107
| 18.898438
| 64
| 44
| 38.89844
| null | null | null | 0.899902
| 141
| null | 145
| 14
| 2,700
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,001
| 0
|
77.36896
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 3,151
| 2,127.6445
| 2,010.47949
| 11
|
white
| 17.097656
| 45
| 0.837891
| 0.734985
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 59
| 7.5
| 72
| 28
| 36.19531
| 266.625
| null | null | 1.699951
| 148
| 7.469727
| 165
| 32
| 2,490
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 825
| 1
|
43.362
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 9
| 12,516
| 8,738.4375
| 8,641.40625
| 18.5
|
white
| 16.898438
| 26
| 0.901978
| 0.866943
| 3
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 9
| 99
| 11
| 69
| 24
| 36.29688
| 183.3125
| 4.5
| 0.399963
| 0.699951
| 136
| 7.359375
| 157
| 15
| 3,200
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 999
| 0
|
54.63699
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 9
|
under $11k
| 0
| 9,328
| 5,555.5078
| 5,620.72656
| 16
|
white
| 24.296875
| 28
| 0.844971
| 0.745972
| 1
| 1
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 4
| 102
| 59.59375
| 130
| 36
| 38.29688
| 264
| 3.299805
| 0.399963
| 0.699951
| 133
| 7.439453
| 166
| 10
| 1,105
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 998
| 0
|
79.33698
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 44
| 31,978
| 20,569.3281
| 20,135.625
| 25
|
white
| 28.597656
| 73
| 0.368958
| 0.250977
| 8
| 0
| 0
|
no
| 0.25
| 0.1
|
dnr after sadm
| 2
| 69
| null | 79
| 16
| 35.89844
| null | null | null | null | 140
| null | null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 8
| 1
|
76.88196
|
male
| 0
| 13
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 8,986
| 6,350.6172
| 6,363.56641
| 3.5
|
hispanic
| 14.398438
| 13
| 0.730957
| 0.459961
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 114
| 30.699219
| 112
| 26
| 36.19531
| 344
| 1.699951
| 1
| 2.199707
| 138
| 7.319336
| 110
| 61
| 3,500
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 224
| 1
|
71.22198
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 5,354
| 3,412.1113
| 2,407.84961
| 5
|
white
| 17.5
| 12
| 0.681885
| 0.386963
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 5
| 117
| 7.199219
| 73
| 20
| 36.59375
| null | 2.699707
| 0.299988
| 0.699951
| 143
| null | 97
| 5
| 3,410
| null | null |
no(M2 and SIP pres)
| 2.0625
| 506
| 1
|
66.823
|
female
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 26
| 135,347
| 89,832.8125
| 92,720
| 40.75
|
white
| 37
| 60
| 0.197998
| 0.105988
| 14
| 0
| 0
|
yes
| 0.2
| 0.2
|
dnr after sadm
| 12
| 84
| 13.699219
| 101
| 8
| 36.29688
| 295.1875
| null | 0.299988
| 0.899902
| 137
| 7.449219
| 150
| 6
| null | null | 1
|
<2 mo. follow-up
| 1
| 36
| 1
|
70.84698
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 26
| 53,893
| 35,381.0312
| 40,310.5625
| 18.333328
|
hispanic
| 13
| 23
| 0.836914
| 0.781982
| 6
| 1
| 0
|
no
| null | null |
no dnr
| 21
| 55
| 14.298828
| 250
| 24
| 35.79688
| 200
| null | null | 0.899902
| 131
| 7.389648
| 213
| 11
| 2,875
| null | 0
| null | 0
| 992
| 0
|
71.99695
|
male
| 0
| 10
|
Lung Cancer
|
Cancer
| 3
| 8
|
$11-$25k
| 0
| 8,201
| 5,417.3125
| 5,474.62891
| 13
|
white
| 24.5
| 31
| 0.507935
| 0.185974
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 68
| 5.099609
| 122
| 22
| 36.69531
| 290.4375
| null | 0.299988
| 0.599976
| 126
| 7.439453
| 200
| 8
| 2,850
| null | 0
|
<2 mo. follow-up
| 0
| 53
| 1
|
52.98599
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 7,862
| 4,907.9609
| 4,835.97656
| 13
|
white
| 14.398438
| 15
| 0.865967
| 0.700928
| 1
| 0
| 0
|
metastatic
| 1
| 0.7
|
no dnr
| 8
| 120
| 10.199219
| 20
| 8
| 40.5
| null | null | null | 1
| 134
| null | 235
| 14
| 1,500
| 0
| null | null | 0.494751
| 179
| 1
|
81.60394
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 6
|
under $11k
| 26
| 4,271
| 2,869.4863
| 2,647.35938
| 18
|
white
| 19.5
| 34
| 0.697998
| 0.533936
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 1
| 114
| 9.699219
| 71
| 24
| 36.39844
| null | null | null | 1.099854
| 134
| null | 189
| 18
| 3,675
| null | null | null | 3.264648
| 305
| 1
|
69.495
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 9
| 49,628
| 33,131.5
| 32,495.4688
| 22
|
white
| 39.796875
| 49
| 0.283997
| 0.174988
| 9
| 0
| 0
|
no
| 0.7
| 0.65
|
no dnr
| 17
| 49
| 7
| 102
| 8
| 38
| 283.3125
| null | null | 0.699951
| 137
| 7.40918
| 252
| 18
| 3,360
| null | 0
|
no(M2 and SIP pres)
| 0
| 987
| 0
|
79.10199
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 6,205
| 4,033.4512
| 3,327.06836
| 11
|
white
| 12.398438
| 12
| 0.849976
| 0.668945
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.2
|
dnr before sadm
| -1
| 69
| 8.898438
| 104
| 24
| 36.29688
| null | 3.099609
| 0.299988
| 1.399902
| 134
| null | 104
| 15
| null | null | null | null | 2.558594
| 94
| 1
|
69.81
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 13
|
under $11k
| 0
| 2,747
| 1,855.1836
| 1,802.7998
| 6
|
white
| 22.5
| 33
| 0.711914
| 0.552979
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
dnr after sadm
| 1
| 115
| 10.099609
| 72
| 24
| 38.09375
| 115.375
| 3.199707
| 0.5
| 1
| 135
| 7.429688
| 131
| 15
| 2,745
| 2
| null |
no(M2 and SIP pres)
| 1.838867
| 149
| 1
|
49.66699
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 41
| 19,633
| 13,279.7969
| 13,310.3672
| 15.666664
|
white
| 31.898438
| 39
| 0.554932
| 0.441956
| 2
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 15
| 61
| 8.298828
| 51
| 24
| 39.19531
| null | 3.299805
| 0.299988
| 0.699951
| 139
| null | 99
| 20
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 986
| 0
|
36.90298
|
female
| 0
| 41
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 142,705
| 89,958.5625
| 96,921.125
| 41
|
white
| 44.898438
| 81
| 0.052994
| 0.016998
| 14
| 0
| 0
|
metastatic
| 0.3
| 0.2
|
no dnr
| 41
| 107
| 10.5
| 112
| 24
| 36.39844
| 428.5625
| null | null | 1.199951
| 138
| 7.509766
| 115
| 12
| 2,885
| null | 0
|
no(M2 and SIP pres)
| 0
| 303
| 1
|
20.67899
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
|
$25-$50k
| 0
| 32,881
| 23,235.1719
| 25,023.4844
| 24
|
hispanic
| 28.597656
| 50
| 0.859985
| 0.810913
| 3
| 0
| 0
|
no
| 0.15
| 0.15
|
no dnr
| 16
| 67
| 9.599609
| 63
| 24
| 38.89844
| 102.03125
| 3.299805
| 0.399963
| 1.799805
| 134
| 7.509766
| 204
| 45
| 3,750
| null | 0
|
no(M2 and SIP pres)
| 0
| 985
| 0
|
67.35095
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 32,054
| 21,528.0625
| 20,462.25
| 19.333328
|
white
| 24.5
| 42
| 0.751953
| 0.672974
| 5
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 15
| 56
| 20.597656
| 74
| 28
| 36.39844
| 423.75
| 2.799805
| 2.799805
| 1.899902
| 134
| 7.469727
| 128
| 30
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 105
| 1
|
56.91199
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 4,438
| 3,007.2383
| 2,494.47852
| 8
|
white
| 20.796875
| 14
| 0.875
| 0.792969
| 1
| 1
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 6
| 66
| 0.399963
| 136
| 26
| 35.59375
| 174.28125
| 2.5
| 0.599976
| 2.299805
| 144
| 7.359375
| 235
| 47
| 2,355
| 2
| null |
no(M2 and SIP pres)
| 1.838867
| 983
| 0
|
89.88397
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 2,318
| 1,608.4033
| 1,264.22949
| 8
|
white
| 21
| 40
| 0.756958
| 0.61499
| 1
| 0
| 0
|
no
| 0.95
| 0.6
|
dnr after sadm
| 1
| 61
| null | 96
| 20
| 36.39844
| null | null | null | null | 140
| null | null | null | 2,800
| null | 1
|
no(M2 and SIP pres)
| 1
| 439
| 1
|
65.99298
|
female
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 118,602
| 78,316
| 74,614.5625
| 20.75
|
white
| 30.199219
| 42
| 0.594971
| 0.485962
| 29
| 1
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 30
| 98
| 4.199219
| 76
| 20
| 37
| null | 2.599609
| 1.599854
| 1.199951
| 136
| null | 124
| 10
| null | null | null | null | 2.907227
| 982
| 0
|
71.98395
|
male
| 0
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 96,019
| 63,468.125
| 59,092.8438
| 21.75
|
white
| 20.398438
| 26
| 0.741943
| 0.661987
| 7
| 1
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 45
| 115
| 10.5
| 74
| 22
| 38.09375
| 112.5
| null | null | 1.699951
| 137
| 7.429688
| 115
| 17
| 2,095
| null | 0
|
no(M2 and SIP pres)
| 0
| 309
| 1
|
80.53894
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
$11-$25k
| 9
| 5,578
| 3,624.8731
| 4,191.1875
| 7
|
white
| 16.5
| 32
| 0.806885
| 0.688965
| 1
| 0
| 1
|
no
| 0.9
| 0.7
|
dnr after sadm
| 1
| 129
| 15.099609
| 136
| 28
| 39.39844
| 106
| 2.599609
| 0.699951
| 5.199219
| 144
| 7.359375
| 118
| 60
| 1,540
| null | 2
|
no(M2 and SIP pres)
| 2
| 976
| 0
|
67.74799
|
male
| 0
| 13
|
Lung Cancer
|
Cancer
| 1
| 20
| null | 37
| 8,261
| 5,839.0312
| 5,178.41797
| 4.5
|
hispanic
| 21.5
| 24
| 0.419983
| 0.116989
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 71
| 11.199219
| 101
| 20
| 36.19531
| null | 3.299805
| 0.399963
| 0.799927
| 139
| null | 154
| 12
| 3,000
| null | null |
<2 mo. follow-up
| 3.527344
| 22
| 1
|
34.491
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 9,067
| 6,019.6328
| 6,112.64844
| 6.5
|
hispanic
| 27.097656
| 38
| 0.557983
| 0.235992
| 1
| 0
| 0
|
metastatic
| 0.05
| 0
|
dnr after sadm
| 7
| 103
| 9.099609
| 63
| 36
| 36
| 216
| 4
| 0.899902
| 1.199951
| 136
| 7.369141
| 136
| 21
| null | null | 3
|
<2 mo. follow-up
| 3
| 10
| 1
|
76.36694
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 8
|
$11-$25k
| 0
| 13,244
| 9,110.2578
| 6,189.46875
| 10.5
|
white
| 20.699219
| 19
| 0.594971
| 0.27594
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
no dnr
| 11
| 109
| 10.398438
| 126
| 36
| 38.29688
| 192
| null | null | 0.699951
| 139
| 7.55957
| 256
| 25
| 5,450
| null | 1
|
<2 mo. follow-up
| 1
| 47
| 1
|
74.43097
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 9,343
| 6,462.2656
| 5,127.62891
| 5.5
|
white
| 24.398438
| 27
| 0.768921
| 0.631958
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr before sadm
| -1
| 56
| 17.699219
| 136
| 30
| 38.69531
| 420.375
| 2.199707
| 1.599854
| 1.199951
| 135
| 7.40918
| 183
| 19
| 2,125
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 973
| 0
|
86.63397
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 2,045
| 1,430.6904
| 1,166.73926
| 6
|
white
| 16.796875
| 25
| 0.830933
| 0.723999
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr before sadm
| -1
| 71
| 11
| 200
| 22
| 36.19531
| null | 3.899902
| 0.399963
| 1.399902
| 136
| null | 119
| 24
| 3,180
| 2
| 0
|
no(M2 and SIP pres)
| 0
| 335
| 1
|
55.22498
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 8
| null | 0
| 1,169
| 768.2168
| 836.09961
| null |
white
| 12.898438
| 11
| 0.79895
| 0.572998
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.4
|
no dnr
| 3
| 100
| 6.099609
| 70
| 40
| 37.59375
| 192
| null | null | 2.199707
| 138
| 7.319336
| 252
| 52
| 1,805
| 2
| null |
no(M2 and SIP pres)
| 1.838867
| 161
| 1
|
66.56494
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 9
| 14,408
| 9,784.1094
| 9,323.80469
| 11
|
white
| 32.195313
| 25
| 0.625
| 0.440979
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 8
| 66
| 13
| 60
| 28
| 35.59375
| null | 3.899902
| 0.799927
| 2.199707
| 142
| null | 129
| 31
| 2,250
| null | 0
| null | 0
| 971
| 0
|
55.82498
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 8,226
| 5,446.2383
| 5,091.07812
| 6
|
white
| 18.699219
| 6
| 0.695923
| 0.407959
| 1
| 0
| 0
|
metastatic
| 0.98
| 0.95
|
no dnr
| 5
| 68
| 7.299805
| 59
| 24
| 35.79688
| 336
| 4.199219
| 1.799805
| 1.699951
| 139
| 7.449219
| 165
| 31
| 1,150
| null | null | null | 2.08252
| 970
| 0
|
83.64099
|
male
| 0
| 56
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 56,792
| 35,551.625
| 33,132.6875
| 11.5
|
white
| 13.398438
| 11
| 0.813965
| 0.698975
| 1
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr before sadm
| 0
| 96
| null | 69
| 20
| 36.89844
| null | null | null | null | 140
| null | null | null | 2,950
| 0
| 0
|
SIP>=30
| 0
| 628
| 1
|
77.28998
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 9
| 72,115
| 47,257.7188
| 47,797.5
| 41.666657
|
white
| 33.195313
| 67
| 0.521973
| 0.405945
| 1
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr after sadm
| 1
| 61
| 7.399414
| 70
| 20
| 36.29688
| 309.5
| 4.299805
| 0.299988
| 1.199951
| 138
| 7.419922
| 124
| 14
| 1,450
| null | 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
85.68695
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 15
| null | 26
| 6,017
| 4,248.1484
| 3,629.04883
| 10.5
|
white
| 22.398438
| 22
| 0.659912
| 0.484985
| 1
| 0
| 1
|
no
| 0.2
| 0.5
|
no dnr
| 7
| 101
| 7.899414
| 72
| 24
| 36.09375
| 252.375
| null | null | 1.199951
| 138
| 7.319336
| 133
| 17
| null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 276
| 1
|
82.97095
|
male
| 1
| 21
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 36,986
| 25,526.625
| 24,256.0312
| 22.333328
|
white
| 24.898438
| 36
| 0.630981
| 0.447998
| 3
| 0
| 0
|
no
| 0.8
| 0.65
|
dnr after sadm
| 21
| 53
| 5.699219
| 120
| 10
| 38
| 130
| 4
| 0.5
| 0.899902
| 131
| 7.439453
| 148
| 11
| 2,320
| null | null |
<2 mo. follow-up
| 3.151367
| 21
| 1
|
43.38898
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 30,170
| 21,486.7188
| 19,866.8125
| 19.333328
|
white
| 25.796875
| 50
| 0.849976
| 0.797974
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 14
| 110
| 12
| 72
| 28
| 35.69531
| 108.15625
| null | null | 2.599609
| 134
| 7.339844
| 144
| 33
| 1,630
| null | 0
|
no(M2 and SIP pres)
| 0
| 968
| 0
|
70.76495
|
male
| 0
| 7
|
Coma
|
Coma
| 2
| 8
| null | 0
| 8,484
| 5,791.332
| 6,613.83984
| 2
|
white
| 16.796875
| 19
| 0.669922
| 0.612915
| 1
| 1
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 1
| 71
| null | 65
| 25
| 38.09375
| null | 3.099609
| 0.599976
| 1.299805
| 141
| null | 157
| 14
| 800
| null | 6
|
<2 mo. follow-up
| 6
| 33
| 1
|
27.63899
|
male
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 83,491
| 62,021.4062
| 64,970.2812
| 36
|
white
| 32
| 62
| 0.740967
| 0.658936
| 4
| 1
| 0
|
yes
| 0.5
| 0.45
|
no dnr
| 39
| 123
| 10.699219
| 60
| 24
| 36.39844
| 244
| 3.699707
| 0.699951
| 1.399902
| 136
| 7.389648
| 110
| 18
| 2,200
| null | 0
|
no(M2 and SIP pres)
| 0
| 964
| 0
|
75.21399
|
female
| 0
| 26
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 18
| null | 61
| 28,177
| 19,605.7812
| 19,261.5469
| 12.25
|
white
| 20.597656
| 20
| 0.414978
| 0.294983
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.25
|
dnr after sadm
| 8
| 71
| 9.298828
| 98
| 24
| 36.79688
| 218.5
| null | null | 0.899902
| 141
| 7.359375
| 117
| 20
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 963
| 0
|
64.159
|
female
| 0
| 29
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 7
| null | 0
| 65,508
| 45,789.5
| 41,963.4062
| 15.25
|
white
| 35.59375
| 83
| 0.259949
| 0.095993
| 23
| 1
| 0
|
no
| 0.5
| 0.2
|
dnr after sadm
| 2
| 39
| 46.09375
| 54
| 28
| 40.09375
| 200
| 3.299805
| 1.299805
| 1
| 130
| 7.369141
| 143
| 53
| null | null | 5
|
<2 mo. follow-up
| 5
| 46
| 1
|
29.32199
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 0
| 61,935
| 40,505.625
| 44,229.25
| 16.333328
|
white
| 23.296875
| 62
| 0.880981
| 0.838989
| 6
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 14
| 59
| 19.199219
| 155
| 30
| 38.79688
| 217.5
| 2.099609
| 3
| 1.699951
| 144
| 7.519531
| 352
| 67
| 670
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 962
| 0
|
78.49097
|
female
| 0
| 16
|
Colon Cancer
|
Cancer
| 1
| 8
|
$11-$25k
| 0
| 17,797
| 11,066.9062
| 10,606.2578
| 10.333328
|
white
| 23.796875
| 19
| 0.664917
| 0.362976
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.7
|
dnr after sadm
| 2
| 135
| 13.599609
| 130
| 24
| 36.39844
| 267.5
| 2.899902
| 19.296875
| 3.299805
| 136
| 7.439453
| 104
| 39
| 8
| 1
| 1
|
<2 mo. follow-up
| 1
| 45
| 1
|
77.80695
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 9
| 7,835
| 5,073.3906
| 4,911.55859
| 10
|
white
| 16.796875
| 29
| 0.819946
| 0.707886
| 1
| 0
| 1
|
no
| 0.75
| 0.5
|
dnr after sadm
| 1
| 61
| 10.699219
| 65
| 22
| 35.19531
| null | 4
| 0.899902
| 1.899902
| 134
| null | 119
| 40
| 2,050
| null | 2
|
no(M2 and SIP pres)
| 2
| 270
| 1
|
64.14197
|
male
| 0
| 29
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 0
| 29,101
| 24,080.6406
| 17,077.8281
| 10.5
|
white
| 32.796875
| 57
| 0.662964
| 0.487976
| 1
| 0
| 0
|
no
| 0.6
| 0.2
|
dnr after sadm
| 1
| 129
| 11.599609
| 160
| 26
| 35.59375
| 180
| null | null | 1.099854
| 136
| 7.359375
| 125
| 16
| 1,165
| 0
| 1
|
<2 mo. follow-up
| 1
| 32
| 1
|
71.83795
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 18,689
| 13,812.0234
| 12,418.1562
| 21.5
|
white
| 23
| 48
| 0.789917
| 0.662964
| 1
| 1
| 0
|
no
| 0.8
| 0.5
|
dnr after sadm
| 7
| 66
| 4.199219
| 62
| 16
| 36.09375
| 368
| 2.899902
| 0.899902
| 1.199951
| 140
| 7.40918
| 106
| 12
| 570
| null | 1
| null | 1
| 575
| 1
|
72.91998
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 2,772
| 1,852.792
| 1,598.87988
| 9
|
white
| 20.199219
| 32
| 0.793945
| 0.668945
| 1
| 0
| 0
|
yes
| 0.9
| 0.5
|
dnr after sadm
| 1
| 128
| 8.599609
| 66
| 32
| 36.5
| 257.125
| 3.899902
| 0.5
| 0.899902
| 137
| 7.369141
| 122
| 16
| 1,725
| 3
| 1
|
no(M2 and SIP pres)
| 1
| 953
| 0
|
72.58295
|
male
| 0
| 10
|
Coma
|
Coma
| 1
| 8
|
under $11k
| 44
| 26,865
| 17,952.7344
| 16,961.9844
| 20.5
|
white
| 24
| 32
| 0.334961
| 0.261963
| 6
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 10
| 97
| 13.398438
| 114
| 20
| 36
| null | 4
| 0.799927
| 0.899902
| 133
| null | 163
| 17
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 951
| 0
|
64.89294
|
male
| 0
| 18
|
Colon Cancer
|
Cancer
| 3
| 12
|
under $11k
| 0
| 18,815
| 12,221.5391
| 13,080.2578
| 9.666664
|
white
| 26.898438
| 36
| 0.635986
| 0.325989
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.1
|
dnr after sadm
| 3
| 66
| 13.798828
| 122
| 36
| 36.39844
| 232.5
| null | null | 0.5
| 129
| 7.469727
| 115
| 14
| 1,950
| 0
| 0
|
<2 mo. follow-up
| 0
| 24
| 1
|
75.33698
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 3,367
| 1,993.8936
| 999.34961
| null |
white
| 17.398438
| 7
| 0.674927
| 0.377991
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 3
| 63
| 7.599609
| 120
| 16
| 38.29688
| null | 3.599609
| 0.699951
| 1.099854
| 140
| null | 105
| 11
| 1,335
| null | 1
| null | 1
| 269
| 1
|
80.698
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
>$50k
| 44
| 15,560
| 10,941.5469
| 10,315.4844
| 12.5
|
white
| 29.296875
| 52
| 0.367981
| 0.250977
| 4
| 0
| 0
|
no
| 0.05
| 0
|
dnr after sadm
| 2
| 79
| null | 77
| 24
| 36.29688
| null | null | null | null | 140
| null | null | null | 2,550
| null | 2
|
<2 mo. follow-up
| 2
| 8
| 1
|
78.62299
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 5
|
under $11k
| 0
| 5,117
| 3,498.4219
| 3,653.75977
| 4
|
white
| 18.5
| 39
| 0.836914
| 0.73291
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 3
| 65
| 5.799805
| 100
| 28
| 36.5
| 276.1875
| 2.5
| 3.599609
| 0.799927
| 135
| 7.5
| 84
| 9
| 1,050
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 294
| 1
|
72.48999
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
| null | 0
| 37,936
| 25,669.4531
| 27,133.8438
| 30.333328
|
white
| 26.199219
| 42
| 0.726929
| 0.642944
| 2
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 78
| 10.699219
| 62
| 20
| 35.69531
| 319
| null | null | 1.099854
| 136
| 7.509766
| 131
| 18
| 1,200
| null | 1
|
no(M2 and SIP pres)
| 1
| 247
| 1
|
72.51495
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 10
| null | 0
| 3,035
| 2,042.083
| 2,346.17969
| 9
|
white
| 21.296875
| 23
| 0.727905
| 0.574951
| 1
| 0
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 5
| 103
| 2.899902
| 67
| 36
| 36.39844
| 309.5
| 4.299805
| 0.699951
| 1
| 138
| 7.469727
| 140
| 11
| null | 1
| null |
adl>=4 (>=5 if sur)
| 1.166748
| 167
| 1
|
74.54297
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 4,039
| 2,884.7246
| 2,318.85938
| 13
|
white
| 19.398438
| 40
| 0.839966
| 0.736938
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 1
| 58
| 10.5
| 70
| 12
| 38.5
| 160
| 2.099609
| 0.699951
| 0.599976
| 134
| 7.469727
| 106
| 9
| 2,990
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 334
| 1
|
84.68695
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$11-$25k
| 0
| 9,362
| 6,366.5742
| 5,481.01953
| 9.5
|
white
| 23.296875
| 37
| 0.68689
| 0.519897
| 1
| 0
| 0
|
no
| 0.9
| 0.65
|
dnr after sadm
| 1
| 61
| 0.699951
| 136
| 30
| 38.59375
| 153.3125
| 3.399902
| 0.299988
| 3.199707
| 133
| 7.329102
| 137
| 52
| 5,225
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 142
| 1
|
73.25397
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
| null | 0
| 7,249
| 5,278.793
| 4,973.81641
| 8
|
white
| 20.097656
| 26
| 0.834961
| 0.72998
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 8
| 71
| null | 98
| 24
| 36.09375
| 180.9375
| 4.5
| 0.299988
| 1.399902
| 143
| 7.369141
| 179
| 28
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 664
| 1
|
70.01196
|
female
| 0
| 11
|
Coma
|
Coma
| 2
| null | null | 0
| 17,659
| 11,679.6562
| 11,399.0078
| 16
|
white
| 16.699219
| 25
| 0.622925
| 0.559937
| 5
| 0
| 0
|
metastatic
| 0.25
| 0.2
|
no dnr
| 11
| 109
| 5.5
| 67
| 22
| 36.39844
| null | 3.399902
| 0.299988
| 0.599976
| 133
| null | 119
| 13
| 3,000
| null | null | null | 2.575684
| 237
| 1
|
51.11298
|
male
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 10
|
under $11k
| 0
| 15,226
| 10,579.2344
| 11,855.9922
| 43
|
white
| 23.296875
| 45
| 0.856934
| 0.806885
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 122
| 8.398438
| 116
| 40
| 36.39844
| 240
| 3.699707
| 0.599976
| 0.699951
| 131
| 7.30957
| 154
| 7
| 1,905
| 2
| null |
<2 mo. follow-up
| 1.838867
| 11
| 1
|
74.39294
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 4,666
| 3,002.5547
| 3,108.58984
| 10
|
white
| 32.695313
| 28
| 0.448975
| 0.136993
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 73
| 7.399414
| 52
| 24
| 35.69531
| null | 3.399902
| 0.299988
| 2.599609
| 135
| null | 122
| 81
| 2,275
| 0
| 0
|
<2 mo. follow-up
| 0
| 38
| 1
|
80.55896
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 4,963
| 3,264.0234
| 4,021.99805
| 5
|
white
| 21.796875
| 24
| 0.748901
| 0.603882
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 7
| 73
| 6.599609
| 65
| 16
| 35.69531
| 309.5
| 4.099609
| 0.399963
| 1.5
| 136
| 7.359375
| 97
| 24
| 2,075
| 5
| 5
|
adl>=4 (>=5 if sur)
| 5
| 86
| 1
|
51.25
|
female
| 0
| 29
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 37
| 114,515
| 73,225.1875
| 74,234.25
| 40.75
|
white
| 45.695313
| 102
| 0.011999
| 0.002
| 10
| 0
| 0
|
yes
| 0.6
| 0.55
|
no dnr
| 29
| 63
| 6.799805
| 73
| 18
| 37
| null | 4.399414
| 0.699951
| 1.199951
| 137
| null | 95
| 3
| 3,000
| null | 0
|
no(M2 and SIP pres)
| 0
| 310
| 1
|
79.90997
|
male
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 6
|
under $11k
| 0
| 65,546
| 46,235.5938
| 42,307.9375
| 23.75
|
white
| 31.199219
| 51
| 0.533936
| 0.418945
| 5
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 15
| 59
| 12
| 70
| 24
| 35.39844
| 409.5
| null | null | 2
| 132
| 7.539062
| 102
| 45
| 1,725
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 937
| 0
|
86.80896
|
male
| 0
| 74
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
| null | 37
| 197,774
| 131,938.75
| 129,221.25
| 33.5
|
white
| 27.097656
| 42
| 0.274963
| 0.166992
| 23
| 0
| 0
|
yes
| 0.05
| 0.01
|
dnr after sadm
| 3
| 63
| 4.599609
| 112
| 52
| 38.59375
| 133.3125
| 2.599609
| 0.199982
| 0.699951
| 134
| 7.519531
| 139
| 4
| 6,500
| null | 0
|
Coma or Intub
| 0
| 891
| 1
|
70.09698
|
female
| 0
| 149
|
Coma
|
Coma
| 4
| 8
|
$11-$25k
| 41
| 254,992
| 191,685.625
| 189,225
| 27.5
|
white
| 22.898438
| 61
| 0.27594
| 0.20697
| 22
| 1
| 0
|
yes
| 0.3
| 0.3
|
no dnr
| 149
| 97
| 78.796875
| 112
| 30
| 35.89844
| 146.125
| null | null | 1.5
| 142
| 7.319336
| 326
| 39
| 1,440
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 936
| 0
|
75.67999
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
| null | 44
| 41,646
| 28,043.875
| 27,575.7812
| 37.5
|
white
| 26.5
| 41
| 0.475952
| 0.357971
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 8
| 104
| 7.099609
| 107
| 24
| 36.09375
| null | 4.199219
| 0.699951
| 1.299805
| 136
| null | 235
| 14
| null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
68.14197
|
male
| 0
| 25
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 29,137
| 19,464.4375
| 20,280.7656
| 3.75
|
white
| 23.199219
| 32
| 0.554932
| 0.232971
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
dnr after sadm
| 14
| 117
| 46.695313
| 156
| 11
| 39.79688
| 205.6875
| null | null | 0.699951
| 148
| 7.439453
| 173
| 26
| 4,000
| 4
| 3
|
<2 mo. follow-up
| 3
| 34
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.